DENVER, CO / ACCESSWIRE / February 5, 2015 / American Cannabis Company Inc. (AMMJ) (“ACC” or the “Company”), a full service cannabis industry consulting and provider of proprietary and preferred products, today announced that its client has been granted two cultivation and processing licenses for the medical marijuana program in the state of Illinois.
ACC has developed a fully integrated business model that features an end-to-end solution for their customers who are entering the cannabis industry. The Company provides premier consulting and advisory services throughout each phase of the process which includes pre-planning for a medical marijuana license, applying for the license, building-out of a lean manufacturing facility, and establishing and managing the protocols to run a world class, compliant, operation.
Corey Hollister, CEO of American Cannabis Company, stated, “The granting of licenses in the state of Illinois was a rigorous and competitive process that has built on what was set forth in previous states. Our ability to assist our client during this process is a testament to our expertise, team and strategy that was set in place to succeed. To date ACC has been successful in securing merit based licenses for clients in CT, MA, NV, and MN. Even more exciting for our team as we successfully move forward is the opportunities to have application clients evolve into multi-year contracts.”
About American Cannabis Company:
American Cannabis Company (“ACC”) offers end-to-end solutions to existing and aspiring participants in the cannabis industry. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. Through our two vertically integrated businesses, American Cannabis Consulting and Trade Winds, a group purchasing organization, we support our clients from concept to creation to commercialization.
For more information, please visit: www.americancannabiscompanyinc.com.
Forward Looking Statements
This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.
Chief Operating Officer
SOURCE: American Cannabis Company Inc.